NE LB533

Amends the Pharmacy Benefit Manager Licensure and Regulation Act to add definitions for "clinician-administered drug" (outpatient prescription drugs that cannot be self-administered and are typically given by a health care provider in clinical settings) and "specialty pharmacy"

Requires specialty pharmacies shipping clinician-administered drugs to comply with federal drug shipment laws, provide 24/7 access to a pharmacist or nurse for questions, and follow track-and-trace requirements under the federal Drug Supply Chain Security Act

Mandates health care providers request delivery of clinician-administered drugs at least five business days in advance, with specialty pharmacies required to obtain signatures upon delivery

Requires pharmacy benefit managers and health carriers to establish and disclose an appeals process allowing exceptions to specialty pharmacy requirements when drugs are not delivered as specified or when immediate use is needed to prevent irreparable harm

Prohibits pharmacy benefit managers and health carriers from requiring specialty pharmacies to dispense clinician-administered drugs directly to patients for transport to a provider; operative date is January 1, 2026